MEDICAL DEVICES · SERVICE DETAILS

Registration and Listing Information Change Service

From the facts before and after the change and the date of the event, the scope of the impact on the business, address, activity, agent and product records is checked, the updates are applied in collaboration and the related specific matters are linked.

Daily changes cannot always wait for annual renewal. Relocation, M & As, or changes in use of the subject or product may involve new records, licences or other obligations, not all of which cannot be covered as original fields.

SERVICE OVERVIEW

What does this service help with?

The verification of the affected facilities, products and related account number records begins with the establishment of the evidence of prior and subsequent changes and supporting evidence. An impact list, updated information, verification submission and version handover could be provided as agreed; Complex identification and product technology issues are identified before being addressed.

WHO MAY NEED IT

Who should consider this service?

A U.S. instrument registration listing record has been established for businesses that need to be updated because of changes in business, location, contact person, agent, activity, manufacturing relationship or product distribution status.

SCOPE & APPROACH

What could the registration and listing information change service include?

Field updates, main site changes and product regulatory impacts are assessed separately and no generic renaming process is used to cover all changes.

01

Change facts and historical records

Reconciling changes, dates of occurrence, relevant laws or business documents, extracting original records and contrasting them and identifying information gaps.

02

Impact assessment of subjects, sites and accounts

Verify whether changes in address, ownership, ownership or activity affect original records and authority, distinguishing between general updates and matters that need to be established or dealt with separately.

03

Product-manufacturing relationship updates

Combining new products, changes in manufacturing sites and activities, suspensions or restorations to match the corresponding pre-market basis and listing data.

04

Association Specific and Time Point Recognition

Identification of affected matters such as agents, UDI/GUDID, labels, pre-marketing or quality procedures and identification of which needs to be completed and which to commission.

05

Review and submission of information

After confirmation and authorization by the client, collaborates with the updating of the agreed records or other applicable actions, follows up on feedback and maintains pre- and post-version versions.

06

Validate and maintain hand in hand

Review of affected system data and application of publicly disclosed findings, legacy issues and matters to be re-examined in the context of the annual review.

GET READY

What to prepare for the assessment

Initial communication may be preceded by a summary and a catalogue of existing records; Detailed information is transferred to the confidentiality arrangements under delegated authority.

  • Existing registered listings and recent acceptance or completion of records
  • Information before and after change, date of occurrence and supporting documentation
  • Information on statutory subjects, places, activities and manufacturing relationships
  • List of changes in product and pre-market basis, suspension restoration, etc.
  • Accounts and authorization, contact and agent arrangements
  • Directory of records that may be affected by labels, UDI or quality
HOW TO START

From initial review to engagement

STEP 01

Collating facts and evidence.

Identify actual changes, time of occurrence and historical records, and avoid direct field coverage.

STEP 02

Demarcation of regulatory impacts and scope

Identify updating, new records or other processing needs, and identify specific division of labour and costs.

STEP 03

Review and collaborative update

Alignment of data and post-authorization processing of applicable matters and recording of feedback and versions.

STEP 04

Verification and handover of follow-up

Check the results and related records to clarify legacy issues and ongoing maintenance responsibilities.

Daily changes cannot always wait for annual renewal. Relocation, M & As, or changes in use of the subject or product may involve new records, licences or other obligations, not all of which cannot be covered as original fields.

TIMING & FEES

Timing and fees

Information reviewed:Fee period: FY 2027, October 1, 2026 through September 30, 2027. For other charges, use the FDA rules as of the review date.

Timing and preparation

Document preparation

Schedules based on the type of change, the physical or physical evidence, the quantity of products affected by the facility and the permission to account; A complex identity, permit or technological change will be judged first.

FDA processing

The FDA system allows for year-round updates; The requirements should be applied to specific matters in a timely manner, not always awaiting the annual window. When new records, pre-market submission or other special purpose are involved, the time is determined in accordance with the corresponding procedures.

Fee breakdown

FDA fees

General registration/list update does not normally have an independent application fee; If a new pre-market submission, annual registration or other charges are triggered, separate checks are required.

Service fees

(a) Analysis by impact, supporting the quantity of documents and records, system processing, feedback and validation of the range of quotations; Whether M & As relocation, re-energization, proxy or technical specialization include separate confirmations.

Other possible costs

Translations, third-party information and special fees such as new registrations, pre-market submission or UDI are listed separately. A normal field update does not exempt other triggered official costs.

OFFICIAL SOURCES

Official grounds for application and maintenance

Data check: 2026-11-06. Specific obligations shall be confirmed in conjunction with the equipment, activities and current application requirements of the FDA.

START WITH YOUR PRODUCT

Please first provide information on the date before and after the change.

Describe changes in the enterprise, facility or product, and identify the scope of the impact and how it is handled. Before a self-help statement, check the type and quantity of changes actually included in the goods and identify them separately.